In addition, we assayed the effect of PARPi on the growth of tumor xenografts formed in immunodeficient mice by subcutaneously injection of SKOV3 and ES2 expressing a non-targeting control (shCtrl) or an shRNA to LSD1 (shLSD1). Here, KDM1A is linked to neoplasm.